Country's first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

The novel mRNA vaccine candidate, HGCO19, is supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news